Command Palette

Search for a command to run...

HESTERBIO
1603.7(-1.59%)
1W: +0.50%

Hester Biosciences Quarterly Results

Charts

YoY Net Sales (Quarterly)
Operating Margin
EPS Growth

Pros & Cons

POSITIVES
  • Revenue growth of 12% in the latest quarter indicates strong demand.
  • Net profit surged to ₹8.39 crore, reflecting operational efficiency.
  • Improved operating margins showcase better cost management.
NEGATIVES
  • Drop in revenue from ₹82.27 crore to ₹63.22 crore indicates volatility.
  • Significant decline in other income, impacting overall profitability.
  • Tax rate spike in the latest quarter reduced net profit margins.

Quarterly Results Data (Numbers are in Crore)

FieldTrendJun 23Sep 23Dec 23Mar 24Jun 24Sep 24Dec 24Mar 25Jun 25
Revenue
87.8570.4566.9879.2582.2783.6963.2281.9284.10
Expenses
73.4957.2456.8363.3364.6264.5358.1662.7461.29
Operating Profit
14.3613.2110.1515.9217.6519.165.0619.1822.81
Other Income
1.154.360.994.151.231.847.81-6.952.32
Interest
2.578.072.196.945.015.89-3.815.621.81
Depreciation
5.404.283.753.744.134.204.294.184.18
Profit Before Tax
8.916.766.419.8710.5911.8713.373.7520.19
Tax
2.202.722.393.473.113.481.962.202.89
Net Profit
6.714.044.026.407.498.3911.411.5417.30
Eps in Rs
7.894.754.737.528.809.8613.411.8220.33

Leveling the playing field in markets.

© 2025 EQHQ Technologies Pvt Ltd

"Information provided is for educational purposes only and not financial advice.